Streptobacillus moniliformis bacteremia in an afebrile patient: A rare case report Authors: Zirong Wu, Lin Zhang, Li Shi, Chunhua Wang, Weiliang Cao Published: 2026 ABSTRACT AbstractRat-bite fever (RBF), caused by Streptobacillus moniliformis, typically presents with fever, rash, and polyarthralgia, but we report an atypical afebrile case in a 36-year-old woman who presented with severe arthralgia and purpuric rash without fever. Laboratory findings revealed leukocytosis, elevated inflammatory markers (CRP 118.77 mg/L, ESR 64 mm/h), and acute kidney injury. Two sets of blood cultures grew Streptobacillus moniliformis, identified by Gram stain, colony morphology, and MALDI-TOF mass spectrometry (Bruker system, score 2.50). Antimicrobial susceptibility testing, performed according to CLSI M100 guidelines, demonstrated sensitivity to penicillin (MIC 0.032 mg/L), ceftriaxone, and other antibiotics. The patient was treated with intravenous penicillin (1.6 million units every 8 h for 14 days) and showed clinical improvement before discharge. This case underscores that fever may be absent in RBF and highlights that, in patients with compatible symptoms (e.g., rash, arthralgia) and potential rodent exposure, blood cultures should be considered even in the absence of fever, especially when other infectious or inflammatory causes are being evaluated, to avoid diagnostic delay.Keywords: Streptobacillus moniliformis, Rat-bite fever, Bacteremia, Afebrile, MALDI-TOF mass spectrometry Introduction Rat-bite fever (RBF), caused by Streptobacillus moniliformis (S. moniliformis), is a rare zoonosis typically presenting with fever, rash, and polyarthralgia [1]. S. moniliformis is a fastidious, Gram-negative, rod-shaped bacterium that often exhibits chain-like formations with moniliform (beaded) swelling [2]. Transmission primarily occurs through bites or scratches from infected rodents, but can also happen indirectly via ingestion of food or water contaminated by rodent excreta or through contact with infected animals [3], [4]. Notably, approximately 30% of patients with RBF report no history of direct rodent bite [5]. The clinical presentation of RBF is marked by significant heterogeneity, lacking pathognomonic hematological abnormalities or specific biomarkers. Consequently, blood culture—requiring specialize media (e.g., tryptic soy broth with 0.1% potassium tellurite) and extended incubation (up to 7 days)—remains the gold standard for definitive diagnosis. Case presentation A 36-year-old woman presented to the emergency department with a 2-day history of arthralgia accompanied by purpura. Her chief complaints were painful swelling and limited movement in both knees and shoulders, along with a scattered, non-pruritic, red pinpoint rash on her trunk and limbs. She also reported generalized myalgia and weakness. Notably, she explicitly reported no fever throughout the disease course, as confirmed by continuous temperature monitoring (range 36.8–37.2℃), and she had not received any antipyretics before or during hospitalization. Exposure history: Upon detailed inquiry, the patient was identified as a rural resident who lived in a household with evidence of rodent activity. She denied any direct rat bite or scratch; however, she reported that she may have consumed food that had been exposed to rats in her home approximately one week prior to symptom onset. Differential diagnosis: The initial differential included acute rheumatic fever, reactive arthritis, immune-complex mediated vasculitis, and sepsis from an unusual pathogen. However, given the acute onset, markedly elevated inflammatory markers, and the patient's history of potential rodent exposure (contaminated food in a rat-infested household), an infectious etiology was prioritized. No extensive rheumatologic work-up was performed because the clinical course (absence of chronic or relapsing symptoms, no clinical features of autoimmune disease such as oral ulcers, photosensitivity, or renal abnormalities) was inconsistent with a primary autoimmune disorder. Physical examination revealed stable vital signs: temperature 36.3°C, respiratory rate 20 breaths/min, pulse 76 beats/min, and blood pressure 106/64 mmHg. Cardiopulmonary and abdominal examinations were normal. Bilateral tenderness and reduced range of motion were noted in the knees and shoulders. Purpuric lesions were observed on all four limbs (Fig. 1 A). No other significant physical signs were found. Initial laboratory tests showed leukocytosis (12.19 × 10⁹/L) with neutrophilia (82.4%), anemia (hemoglobin 109 g/L), and mild thrombocytopenia (108 × 10⁹/L). Inflammatory markers were elevated: erythrocyte sedimentation rate (ESR) was 64 mm/h and C-reactive protein (CRP) was 118.77 mg/L. Procalcitonin was 1.04 ng/mL. Liver function tests were notable for an AST of 45.3 IU/L and albumin of 34.48 g/L. Renal impairment was evident with elevated creatinine (149.2 μmol/L), blood urea nitrogen (18.41 mmol/L), and uric acid (504.6 μmol/L). Electrolyte imbalances included hypokalemia (3.19 mmol/L), hyponatremia (130.44 mmol/L), and hypochloremia (95.05 mmol/L). A: Scattered purpura on the skin of the patient's limbs upon admission to the hospital; B:The colony morphology of Streptobacillus moniliformis after 48 h of cultivation; C: Morphology under Gram staining of Streptobacillus moniliformis (×1000); D: Comparison results of mass spectrometry identification of Streptobacillus moniliformis. The patient was admitted for further management. Blood cultures were drawn, and empirical intravenous ceftriaxone (2 g once daily) was initiated. Throughout her hospitalization, she remained afebrile without antipyretics. After 4 days of incubation, the blood cultures signaled positive, and the isolate was subsequently identified as S. moniliformis. Based on the antimicrobial susceptibility testing results, her antibiotic regimen was tailored to intravenous penicillin (1.6 million units every 8 h). The empirical ceftriaxone had been given for 4 days before the switch. After 14 days of treatment, the patient showed significant clinical improvement and was discharged. Microbiological Identification: Two sets of blood cultures (aerobic and anaerobic bottles, BACTEC FX, BD) were collected at a 10-minute interval. Both aerobic bottles flagged positive after 22 h of incubation. Gram staining of the broth revealed Gram-negative bacilli arranged in chains. Subcultures on blood agar and chocolate agar were incubated at 35°C in a 5% CO₂ atmosphere. After 24 h, a thin film of growth was observed on the blood agar, without distinct colonies. After 48 h, small (1–2 mm in diameter), circular, raised, brownish, translucent, and moist colonies with a "fried-egg" appearance and β-hemolysis were evident (Fig. 1 B). Gram stain from the colonies confirmed Gram-negative rods, often forming long filaments up to 150 μm with moniliform swellings (Fig. 1 C). The organism was non-motile, catalase-negative, and lacked spores and capsules. It was conclusively identified as S. moniliformis with a high confidence score (Score 2.50) using the Bruker MALDI-TOF mass spectrometry system (Fig. 1 D). Antimicrobial susceptibility testing, performed according to CLSI M100 guidelines using the microbroth dilution method (MIC method), demonstrated sensitivity to penicillin (MIC 0.032 mg/L), ceftriaxone, tetracycline, gentamicin, ciprofloxacin, levofloxacin, ceftazidime, cefotaxime, and imipenem. Discussion S. moniliformis infection typically presents with a classic triad of symptoms. Literature indicates high frequencies of fever (92%), rash (61%), and polyarthralgia (66%), among other symptoms like nausea, vomiting, and headache [2]. Transmission is commonly associated with rodent bites or contact with their secretions/excreta, but indirect transmission via contaminated food or pet exposure has been documented [4], [6]. Notably, as reported by S. P. Elliott, approximately 30% of RBF patients have no history of direct rodent bite [5], consistent with our patient's exposure history of consuming food potentially contaminated by rats. Untreated, RBF can lead to severe complications in 7–13% of cases, including endocarditis and meningitis, underscoring the critical need for early diagnosis and treatment [7]. This case is noteworthy because the patient's primary manifestations were arthralgia and purpura, and she remained afebrile—a presentation that deviates from the classic description and could easily lead to diagnostic delay or misdirection. The elevated inflammatory markers (CRP, ESR, PCT) were crucial clues prompting a thorough infectious workup, culminating in blood cultures. The definitive diagnosis was facilitated by modern technology, specifically MALDI-TOF mass spectrometry, which allows for rapid and accurate identification of fastidious organisms like S. moniliformis. As noted by Eisenberg et al., MALDI-TOF MS can effectively identify Streptobacillus species when appropriate reference spectra are available [8]. Regarding treatment, penicillin remains the first-line therapy for RBF caused by S. moniliformis [5], [9], [10]. In our case, the isolate demonstrated in vitro susceptibility to penicillin (MIC 0.032 mg/L), and the patient received intravenous penicillin (1.6 million units every 8 h for 14 days) with good clinical response. This treatment regimen is consistent with previous reports recommending penicillin as the preferred agent due to its efficacy, low toxicity, and cost-effectiveness [9], [11]. For penicillin-allergic patients, alternative agents such as ceftriaxone or tetracyclines may be considered [5]. This report serves two key purposes: First, it enhances our understanding of the variable clinical spectrum of RBF, demonstrating that the absence of fever does not rule out the diagnosis. Second, while elevated inflammatory markers (CRP, ESR, leukocytosis) are non-specific and can be seen in many non-infectious conditions, in patients with otherwise unexplained systemic symptoms compatible with RBF (e.g., rash, severe arthralgia) and a history of potential rodent exposure—even without fever—blood cultures remain a valuable diagnostic step. Clinicians should not rely on inflammatory markers alone but should integrate them with clinical suspicion and exposure history. CRediT authorship contribution statement Weiliang Cao: Writing – review & editing, Writing – original draft, Funding acquisition, Formal analysis, Data curation, Conceptualization. Li Xianguo: Conceptualization, Data curation, Funding acquisition. Zirong Wu: Conceptualization. Lin Zhang: Data curation. Li Shi: Writing – review & editing, Writing – original draft, Data curation. Chunhua Wang: Writing – review & editing, Data curation. Ethical form All protocols in this study were approved by the Ethics Committee of Xiangyang No. 1 People's Hospital (XYYYE20240099). Declaration of Generative AI and AI-assisted technologies in the writing process The AI tool was used to improve readability, grammar, and sentence flow. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. No AI tool was used to generate original scientific content, data, analysis, or conclusions. Funding This work was supported by the Faculty Development Grants of Xiangyang No.1 People's Hospital Affiliated to Hubei University of Medicine (Grant No. XYY2025DQ07) and the Projects of Natural Science Foundation of Hubei Province (Grant No. 2025AFD045). Declaration of Competing Interest The authors declare no conflict of interest. Contributor Information Chunhua Wang, Email: wchdye@163.com. Weiliang Cao, Email: 790561571@qq.com. Data availability The data supporting the findings of this report are available from the corresponding author upon reasonable request. References Associated Data Data Availability Statement The data supporting the findings of this report are available from the corresponding author upon reasonable request.